Lipid Nanoparticles with Stiripentol and Cannabidiol Oil: From Rational Optimization to Preclinical Characterization

<b>Background/Objectives</b>: Dravet Syndrome (DS) is a severe form of epilepsy that typically manifests in the first year of life and often requires polytherapy with two or more antiseizure medications (ASMs) to achieve adequate seizure control. Whereas the combination of stiripentol (STP) and cann...

Descripció completa

Dades bibliogràfiques

Autors principals:	Sebastián Scioli-Montoto, Martin Lobos, Mauricio Melis, Santiago Ruatta, Giuliana Muraca, Cecilia Yamil Chain, Sebastián Cisneros, Vera Alejandra Alvarez, German Islan, Alan Talevi, María Esperanza Ruiz
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2026-04-01
Col·lecció:	Pharmaceutics
Matèries:	cannabidiol Dravet syndrome lipid nanoparticles nanostructured lipid carriers oral administration pediatric formulations
Accés en línia:	https://www.mdpi.com/1999-4923/18/4/503
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!